Early research (Phase 1)Study completedNCT00293488What this trial is testingSL-11047 in Treating Patients With Relapsed or Refractory LymphomaWho this might be right forLymphoma Progen Pharmaceuticals 20
Testing effectiveness (Phase 2)Study completedNCT00002552What this trial is testingChemotherapy Plus Bone Marrow Transplantation in Treating Patients With Refractory Non-Hodgkin's Lymphoma, Hodgkin's Disease, or Multiple MyelomaWho this might be right forLymphomaMultiple Myeloma and Plasma Cell Neoplasm Barbara Ann Karmanos Cancer Institute 40
Early research (Phase 1)Active Not RecruitingNCT04007029What this trial is testingModified Immune Cells (CD19/CD20 CAR-T Cells) in Treating Patients With Recurrent or Refractory B-Cell Lymphoma or Chronic Lymphocytic LeukemiaWho this might be right forCD19 PositiveCD20 PositiveRecurrent Chronic Lymphocytic Leukemia+11 more Jonsson Comprehensive Cancer Center 24
Testing effectiveness (Phase 2)Study completedNCT03740529What this trial is testingOral LOXO-305 in Patients With Previously Treated CLL/SLL or NHLWho this might be right forChronic Lymphocytic LeukemiaWaldenstrom MacroglobulinemiaMantle Cell Lymphoma+3 more Loxo Oncology, Inc. 803
Early research (Phase 1)Study completedNCT01484015What this trial is testingProlonged or Standard Infusion of Cefepime Hydrochloride in Treating Patients With Febrile NeutropeniaWho this might be right forAdult Acute Lymphoblastic LeukemiaAdult Acute Myeloid LeukemiaAdult Burkitt Lymphoma+36 more Wake Forest University Health Sciences 70
Testing effectiveness (Phase 2)Ended earlyNCT00121186What this trial is testingS0501 Fludarabine, Melphalan, and Donor Stem Cell Transplant Followed By Tacrolimus and Methotrexate in Treating Patients for Relapsed LymphomaWho this might be right forLymphoma SWOG Cancer Research Network 1
Early research (Phase 1)Active Not RecruitingNCT05753501What this trial is testingStudy to Evaluate Adverse Events, Change in Disease Activity, and How Oral ABBV-101 Moves Through the Body in Adult Participants With B-Cell MalignanciesWho this might be right forHematologic Cancer AbbVie 135
Testing effectiveness (Phase 2)Ended earlyNCT00543582What this trial is testingMGCD0103 Administered in Combination With Azacitidine (Vidaza®) to Subjects With Relapsed or Refractory Hodgkin or Non-Hodgkin LymphomaWho this might be right forHodgkin LymphomaNon-Hodgkin Lymphoma (Follicular or Large Diffuse B-cell Lymphoma or Mantle Cell Lymphoma) Mirati Therapeutics Inc. 23
Testing effectiveness (Phase 2)Study completedNCT01110135What this trial is testingBendamustine Hydrochloride, Etoposide, Dexamethasone, and Filgrastim For Peripheral Blood Stem Cell Mobilization in Treating Patients With Refractory or Recurrent Lymphoma or Multiple MyelomaWho this might be right forAdult Nasal Type Extranodal NK/T-cell LymphomaAnaplastic Large Cell LymphomaAngioimmunoblastic T-cell Lymphoma+26 more University of Washington 43
Not applicableStudy completedNCT00856388What this trial is testingFludarabine Phosphate, Melphalan, Total-Body Irradiation, Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer or Bone Marrow Failure DisordersWho this might be right forAccelerated Phase Chronic Myelogenous LeukemiaAcute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic SyndromeAdult Acute Lymphoblastic Leukemia in Remission+97 more Roswell Park Cancer Institute 62
Testing effectiveness (Phase 2)Study completedNCT00062296What this trial is testingEpirubicin and Rituximab in Treating Patients With Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma or Chronic Lymphocytic LeukemiaWho this might be right forLeukemiaLymphoma Fox Chase Cancer Center 5
Early research (Phase 1)Study completedNCT00019513What this trial is testingCombination Chemotherapy in Treating Patients With Recurrent, Refractory, or Metastatic Solid Tumors or LymphomasWho this might be right forColorectal CancerEsophageal CancerExtrahepatic Bile Duct Cancer+7 more National Institutes of Health Clinical Center (CC) 108
Not applicableStudy completedNCT02037256What this trial is testingBortezomib and Filgrastim to Promote Stem Cell Mobilization in Patients With Non-Hodgkin Lymphoma or Multiple MyelomaWho this might be right forAdult Grade III Lymphomatoid GranulomatosisB-cell Chronic Lymphocytic LeukemiaContiguous Stage II Adult Burkitt Lymphoma+86 more Barbara Ann Karmanos Cancer Institute 23
Testing effectiveness (Phase 2)Study completedNCT01177371What this trial is testingHigh-Dose Busulfan and High-Dose Cyclophosphamide Followed By Donor Bone Marrow Transplant in Treating Patients With Leukemia, Myelodysplastic Syndrome, Multiple Myeloma, or Recurrent Hodgkin or Non-Hodgkin LymphomaWho this might be right forAccelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Megakaryoblastic Leukemia (M7)+70 more Case Comprehensive Cancer Center 13
Early research (Phase 1)Study completedNCT00045500What this trial is testingUCN-01 and Prednisone in Treating Patients With Solid Tumors or LymphomaWho this might be right forLymphomaUnspecified Adult Solid Tumor, Protocol Specific National Cancer Institute (NCI)
Not applicableStudy completedNCT00098566What this trial is testingLong-Term Effects of Iodine I Tositumomab and Autologous Bone Marrow or Stem Cell Transplantation in Patients With Relapsed or Refractory Non-Hodgkin's LymphomaWho this might be right forLymphomaQuality of Life Fred Hutchinson Cancer Center 36
Early research (Phase 1)Study completedNCT03329950What this trial is testingCDX-1140 (CD40) as Monotherapy or in Combination in Patients With Advanced MalignanciesWho this might be right forMelanomaNon-small Cell Lung CancerBreast Cancer+23 more Celldex Therapeutics 132
Testing effectiveness (Phase 2)Looking for participantsNCT03314974What this trial is testingMyeloablative Allo HSCT With Related or Unrelated Donor for Heme DisordersWho this might be right forAcute LeukemiaAcute Myeloid LeukemiaAcute Lymphoblastic Leukemia+25 more Masonic Cancer Center, University of Minnesota 300
Testing effectiveness (Phase 2)Study completedNCT00003210What this trial is testingInterleukin-12 in Treating Patients With Previously Treated Non-Hodgkin's Lymphoma or Hodgkin's DiseaseWho this might be right forExtranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid TissueNodal Marginal Zone B-cell LymphomaRecurrent Adult Diffuse Large Cell Lymphoma+14 more National Cancer Institute (NCI) 105
Early research (Phase 1)Study completedNCT00458731What this trial is testingBevacizumab and Cediranib Maleate in Treating Patients With Metastatic or Unresectable Solid Tumor, Lymphoma, Intracranial Glioblastoma, Gliosarcoma or Anaplastic AstrocytomaWho this might be right forAdult Grade III Lymphomatoid GranulomatosisAdult Nasal Type Extranodal NK/T-cell LymphomaAnaplastic Large Cell Lymphoma+59 more National Cancer Institute (NCI) 57